MedPath

Comparison of sumatriptan and propofol VS Sumatriptan and placebo in acute migraine

Not Applicable
Conditions
Migraine.
Migraine without aura (common migraine )
G43.2-G43.
Registration Number
IRCT2015050422089N1
Lead Sponsor
Vice chancellor for research, Shahid Sadoughi university of Medical Science Of Yazd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

all patient aged 18 to 45 years old with migrain headache
Exclusion criteria: Pregnancy, Hypertension, Previous CVA, propofol sensitivity, Sumatriptan sensitivity, coronary artery disease.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Before intervention, 10-minute iterval after intervention until 1 hour. Method of measurement: Visual pain score.
Secondary Outcome Measures
NameTimeMethod
Hypoxia. Timepoint: Before intervention, 10- minute interval after intervention until 1 hour. Method of measurement: Pulse oximetry.
© Copyright 2025. All Rights Reserved by MedPath